Revumenib Revises the Treatment Landscape for KMT2A-r Leukemia. Heikamp EB, Armstrong SA. J Clin Oncol 2024 Nov 7:JCO2401265. doi: 10.1200/JCO-24-01265.

Read + Share

Amedeo Smart

Independent Medical Education

Heikamp EB, Armstrong SA. Revumenib Revises the Treatment Landscape for KMT2A-r Leukemia. J Clin Oncol 2024 Nov 7:JCO2401265. doi: 10.1200/JCO-24-01265.
PMID: 39509656